Baumgartner G R, Rowen R C
Arch Intern Med. 1987 Jul;147(7):1223-6.
To our knowledge, this is the first reported comparison of clonidine with benzodiazepine in the management of acute alcohol withdrawal syndrome. In a double-blind trial, 61 men experiencing acute alcohol withdrawal were randomly assigned to receive clonidine or chlordiazepoxide over a 60-hour treatment period. Clonidine was more effective than chlordiazepoxide at reducing alcohol withdrawal scale scores, systolic blood pressures, and heart rates over the entire study period. Clonidine was as good as chlordiazepoxide at improving Cognitive Capacity Screening Exam, Hamilton Anxiety Rating Scale, and Self-Rating Scale scores. Adverse drug reactions reported by each group were similar, though less nausea and vomiting were observed in the clonidine group. Clonidine may represent a new alternative agent for the management of acute alcohol withdrawal syndrome.
据我们所知,这是首次报道的可乐定与苯二氮䓬类药物在急性酒精戒断综合征管理中的比较。在一项双盲试验中,61名经历急性酒精戒断的男性在60小时的治疗期内被随机分配接受可乐定或氯氮䓬治疗。在整个研究期间,可乐定在降低酒精戒断量表评分、收缩压和心率方面比氯氮䓬更有效。在改善认知能力筛查测试、汉密尔顿焦虑量表和自评量表评分方面,可乐定与氯氮䓬效果相当。每组报告的药物不良反应相似,不过可乐定组观察到的恶心和呕吐较少。可乐定可能是急性酒精戒断综合征管理的一种新的替代药物。